References
- Basile, L., Jansa, J. M., Carlier, Y., Salamanca, D. D., Angheben, A., Bartoloni, A., … Albajar-Vinas, P. (2011). Chagas disease in European countries: The challenge of a surveillance system. Eurosurveillance, 16(37).
- Bern, C., Kjos, S., Yabsley, M. J., & Montgomery, S. P. (2011). Trypanosoma cruzi and chagas' disease in the United States. Clinical Microbiology Reviews, 24, 655–681. doi:10.1128/CMR.00005-11
- Beyrer, C., Villar, J. C., Suwanvanichkij, V., Singh, S., Baral, S. D., & Mills, E. J. (2007). Neglected diseases, civil conflicts, and the right to health. Lancet, 370, 619–627. doi:10.1016/S0140-6736(07)61301-4
- CDC. (2010). American trypanosomiasis. Retrieved from http://www.cdc.gov/parasites/chagas/biology.html
- CDC. (2013). Neglected tropical diseases. Retrieved from http://www.cdc.gov/globalhealth/ntd/diseases/otherntds.html
- CEWG. (2012). Research and development to meet health needs in developing countries: Strengthening global financing and coordination report. Report of the consultative expert working group on research and development. Geneva: World Health Organization.
- Chatelain, E., & Loset, J. R. (2011). Drug discovery and development for neglected diseases: The DNDi model. Drug Design, Development and Therapy, 5, 175–181. doi:10.2147/DDDT.S16381
- CHRD. (1990). Health research: Essential link to equity in development. New York, NY: Oxford University Press.
- CIPIH. (2006). Public health, innovation and intellectual property rights: Report of the commission on intellectual property rights, innovation and public health. Geneva: World Health Organization.
- Collier, P. (2007). The bottom billion: Why the poorest countries are falling and what can be done about it. Oxford: Oxford University Press.
- Cooper, M. (2008). Life as surplus. Washington, DC: University of Washington Press.
- Coura, J. R., & de Castro, S. L. (2002). A critical review on chagas disease chemotherapy. Memorias do Instituto Oswaldo Cruz, 97(1), 3–24. doi:10.1590/S0074-02762002000100001
- Davies, S. E. (2008). Securitizing infectious disease. International Affairs, 84, 295–313. doi:10.1111/j.1468-2346.2008.00704.x
- Elbe, S. (2010). Security and global health: Towards the medicalization of insecurity. Cambridge: Polity Press.
- Farmer, P. (1996). Social inequalities and emerging infectious diseases. Emerging Infectious Diseases, 2, 259–269. doi:10.3201/eid0204.960402
- Fidler, D. P., & Gostin, L. O. (2006). The new international health regulations: An historic development for international law and public health. Journal of Law, Medicine & Ethics, 34(1), 85–94. doi:10.1111/j.1748-720X.2006.00011.x
- Hotez, P. (2009). Neglected diseases amid wealth in the United States and Europe. Health Affairs, 28, 1720–1725. doi:10.1377/hlthaff.28.6.1720
- Hotez, P., Molyneux, D., Fenwick, A., Kumaresan, J., Sachs, S., Sachs, J., & Savioli, L. (2007). Control of neglected tropical diseases. New England Journal of Medicine, 357, 1018–1027. doi:10.1056/NEJMra064142
- Hotez, P., & Pecoul, B. (2010). “Manifesto” for advancing the control and elimination of neglected tropical diseases. PLoS Neglected Tropical Diseases, 4(5), e718. doi:10.1371/journal.pntd.0000718
- Hotez, P., & Thompson, T. (2009). Waging peace through neglected tropical disease control: A US foreign policy for the bottom billion. PLoS Neglected Tropical Diseases, 3(1), e346. doi:10.1371/journal.pntd.0000346
- Hulme, D. (2007). The making of the millennium development goals: Human development meets results based management in an imperfect world. Manchester: Brooks World Poverty Institute.
- IOM. (1997). America's vital interests in global health: Protecting our people, enhancing our economy, and advancing our international health interests. Washington, DC: The National Academies Press.
- IOM. (2010). The causes and impacts of neglected tropical and zoonotic diseases: Opportunities for integrated intervention strategies. Retrieved from http://www.iom.edu/Activities/PublicHealth/MicrobialThreats/2010-SEP-21.aspx
- King, N. (2002). Security, disease, commerce: Ideologies of postcolonial global health. Social Studies of Science, 32, 763–789. doi:10.1177/030631202128967406
- Koplan, J. P., Bond, T. C., Merson, M. H., Reddy, K. S., Rodriguez, M. H., Sewankambo, N. K., & Wasserheit, J. N. (2009). Towards a common definition of global health. Lancet, 373, 1993–1995. doi:10.1016/S0140-6736(09)60332-9
- Lakoff, A. (2008). The generic biothreat, or, how we became unprepared. Cultural Anthropology, 23, 399–428. doi:10.1111/j.1548-1360.2008.00013.x
- Lakoff, A. (2010). Two regimes of global health. Humanity, 1(1), 59–79. doi:10.1353/hum.2010.0001
- Lederberg, J., Shope, R., & Oaks, S. (1992). Emerging infections: Microbial threats to health in the United States. Washington, DC: National Academy Press.
- Lee, B., Bacon, K., Bottazzi, M., & Hotez, P. (2013). Global economic burden of chagas disease: A computational simulation model. Lancet Infectious Diseases, 13, 342–348. doi:10.1016/S1473-3099(13)70002-1
- Manne, J., Snively, C. S., Levy, M. Z., & Reich, M. R. (2012). Supply chin problems for chagas disease treatment. Lancet Infectious Diseases, 12(3), 173–175. doi:10.1016/S1473-3099(12)70001-4
- Maruthappu, M., & Williams, C. (2013). The biomarket. Global Public Health, 8(1), 106–119. doi:10.1080/17441692.2012.758300
- Mectizan Donation Program. (2013). Achievements. Retrieved from http://www.mectizan.org/achievements
- Morse, S. (1995). Factors in the emergence of infectious diseases. Emerging Infectious Diseases, 1(1), 7–15. doi:10.3201/eid0101.950102
- MSF. (1999a). The access campaign. Retrieved from http://www.msfaccess.org/
- MSF. (1999b). Nobel Lecture. Retrieved from http://www.nobelprize.org/nobel_prizes/peace/laureates/1999/msf-lecture.html
- MSF. (2001). Fatal imbalance: The crisis in research and development for drugs for neglected diseases. Geneva: MSF Access to Essential Medicines Campaign.
- MSF. (2010). US congressional malaria & NTD caucus briefing: Controlling deadly neglected tropical diseases. Opportunities to expand the U.S. impact. Retrieved from http://www.doctorswithoutborders.org/publications/article.cfm?id=4275&cat=transcript
- Nuyens, Y. (2007). Setting priorities for health research: Lessons from low- and middle-income countries. Bulletin of the World Health Organization, 85, 319–321. doi:10.2471/BLT.06.032375
- Pecoul, B., Chirac, P., Trouiller, P., & Pinel, J. (1999). Access to essential drugs in poor countries: A lost battle? JAMA, 281, 361–367. doi:10.1001/jama.281.4.361
- Pedrique, B., Strub-Wourgaft, N., Some, C., Olliaro, P., Trouiller, P., Ford, N., … Bradol, J.-H. (2013). The drug and vaccine landscape for neglected diseases (2000–11): A systematic assessment. The Lancet Global Health, 1(6), e371–e379. doi:10.1016/S2214-109X(13)70078-0
- People's Health Movement, Medact, Health Action International, Medico International and Third World Network (2011). Global health watch 3: An alternative world health report. London: Zed Books.
- Satcher, D. (1995). Emerging infections: Getting ahead of the curve. Emerging Infectious Diseases, 1(1), 1–6. doi:10.3201/eid0101.950101
- Stephenson, N. (2011). Emerging infectious disease/emerging forms of biological sovereignty. Science, Technology and Human Values, 36, 616–637. doi:10.1177/0162243910388023
- Trouiller, P., Olliaro, P., Torreele, E., Orbinski, J., Laing, R., & Ford, N. (2002). Drug development for neglected diseases: A deficient market and a public-health policy failure. Lancet, 359, 2188–2194. doi:10.1016/S0140-6736(02)09096-7
- Trouiller, P., Torreele, E., Olliaro, P., White, N., Foster, S., Wirth, D., & Pecoul, B. (2001). Drugs for neglected diseases: A failure of the market and a public health failure? Tropical Medicine and International Health, 6, 945–951. doi:10.1046/j.1365-3156.2001.00803.x
- UNGASS. (2000). United Nations millennium declaration. Retrieved from http://www.un.org/millennium/declaration/ares552e.htm
- Uniting to Combat Neglected Tropical Diseases. (2012). The London declaration on neglected tropical diseases. Retrieved from http://www.unitingtocombatntds.org/downloads/press/london_declaration_on_ntds.pdf
- WHO. (1978). The declaration of Alma Ata. Geneva: Author.
- WHO. (2007). A safer future: Global public health security in the 21st century. Geneva: Author.
- WHO. (2010a). Working to overcome the global impact of neglected tropical diseases: First WHO report on neglected tropical diseases. Retrieved from http://whqlibdoc.who.int/publications/2010/9789241564090_eng.pdf
- WHO. (2010b). Chagas disease in Europe. Retrieved from http://www.who.int/neglected_diseases/integrated_media_chagas_statement/en/index.html
- WHO. (2013). Sustaining the drive to overcome the global impact of neglected tropical diseases. Geneva: Author.
- Williams, O. D. (2012). Access to medicines, market failure and market intervention: A tale of two regimes. Global Public Health, 7( Suppl 2), S127–S143. doi:10.1080/17441692.2012.725753